This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinicaltrial data published in the journal Trauma Surgery & Acute Care. Sixty-six patients participated in the study. Half of the participants received dronabinol and the other half did not.
The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.
In light of such, and the fact that cancer is a common qualifying condition for cannabis, this research team took to expanding the available basic information on cannabis in the cancer population in order to provide clinicaltrial designers with better information needed for planned studies. Cancer Patients Experience Less Severe Pain.
Because there is limited or conflicting research about “the true nature of traumatic brain injury and how it causes chronic degenerative problems,” treatment can be a challenging process for many patients. One medication may work for one patient, but might be ineffective for another TBI patient.
Most commonly, patients report that tingling and numbness occur, usually in the hands and feet. Exposure to toxins may damage nerves and cause peripheral neuropathy: medication toxicity, environmental or industrial toxins and heavy alcohol consumption. Neuropathy, or nerve damage, effects over 30 million Americans. Autoimmune diseases.
The CBD she took may or may not have helped, but according to a recent survey of tinnitus patients, she wasn’t alone in trying — or at least in being interested in cannabis as a potential remedy. But many more patients were willing to try, perhaps as an indication of the intractability of chronic tinnitus.
In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Of these consumers, over half said the drug had a beneficial clinical effect on their condition. Patients can also access CBD products without a prescription through local pharmacies.
Cannabis and immunotherapy have both gained traction in the oncology field in recent years — one to help treat symptoms and the other as a gentler alternative to chemotherapy — but there’s been some concern that for cancer patients using both, the former could interfere with the latter. THC for Tumors?
Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. To date, very few human clinicaltrials have been conducted to assess the effectiveness of THC or CBD in treating cancer. The answer: Maybe!
In January of 2020, the Journal of the American College of Cardiology published a review titled Marijuana Use in Patients With Cardiovascular Disease. Few randomized clinicaltrials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk. population, has an arrhythmia.
Clinicaltrials into cannabis’ potential as an opioid replacement are well underway in South Africa. We are currently recruiting patients, and data-capturing all the questionnaires and feedback from the patients for the live study. Quite frankly, the clinicaltrials couldn’t have come at a better time.
Harvard University scientist Staci Gruber shared encouraging results from “the first open-label to double-blind clinicaltrial” assessing the impact of a high- CBD , low- THC sublingual tincture in patients who experience moderate anxiety. Results highlight the need for expanded patient access to CBD products.”.
There are a variety of treatment options to help patients cope with and heal from anxiety disorders. Medical marijuana is another option for patients suffering from anxiety. The authors determined that patients are increasingly seeking Cannabis to treat a broad range of medical conditions.
Separate provisions in the bill exclude cannabidiol from the federal definition of marijuana, permit VA doctors to authorize medical cannabis access to qualified patients, and remove undue federal barriers to clinicaltrial research to better assess the safety and efficacy of medical cannabis. NH resident? GA resident?
The most recent one , from June 2021, takes a look at patients using cannabis to relieve pain. Over the prior three years or so, 41,260 RYAH-connected patients reported medical cannabis use for the treatment of pain. RYAH examined reporting from 17,313 such patients over the course of about 3 ½ years.
Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. In 2019, Japan approved clinicaltrials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes. Shutterstock).
For those who might be exploring the benefits of cannabis or are considering its many therapeutic effects, Cannabidiol, often abbreviated as CBD is especially important for cannabis patients. Cannabinoids are chemicals within cannabis that offer relief to patients, similar to natural compounds in our body called endocannabinoids.
Interestingly, smoking (combustion) is believed to produce the most CBN when consumed, which could be due to higher temperatures that are achieved during consumption. A 2012 study in rats compared the effects of CBD, CBG, and CBN on food consumption and showed that unlike the others, CBN increased feeding.
Harvard University scientist Staci Gruber shared encouraging results from “the first open-label to double-blind clinicaltrial” assessing the impact of a high- CBD , low- THC sublingual tincture in patients who experience moderate anxiety. Results highlight the need for expanded patient access to CBD products.”.
Fibromyalgia patients suffering from lower back pain respond favorably to medical cannabis as a treatment, according to a new study published in the journal Clinical and Experimental Rheumatology , and epublished by the National Institute of Health.
In December of 2023, the country recently made a new move towards reform that could stimulate the cannabidiol (CBD) industry and provide many patients, such as those with epilepsy , with access to potentially life-changing medical treatments. and Europe to treat severe epilepsy, as well as other medical conditions.
An Introductory Lesson on THC Basics For Medical Cannabis Patients. Cannabis, a plant that has proven to be endlessly complex is still under the microscope by researchers, patients, physicians, and society. But many new patients need an introduction on THC basics, learning how it plays a role in a patient’s well-being and healing.
If having an MMJ card has adverse impacts on consumption, the public has a right to know; at the same time, the convoluted nature of the research makes it very easy to misinterpret and misunderstand the findings. ClinicalTrial Sample Size. a necessary question to address as medical marijuana becomes more accessible.
Clinically, there are published reports of the potential benefits of Salvia divinorum in the treatment of TRD. Karl Hanes reported on 7 patients with TRD who described relief from depressive symptoms with continued oral consumption of salvia leaves three times a week.
Patients often struggle with symptoms that range from physical discomfort to cognitive impairment. In this article, we explore how medical marijuana for multiple sclerosis symptoms helps patients, with its diverse cannabinoid components, alleviate MS symptoms, and enhance the quality of life for patients.
This speaks to the relationship between anxiety levels and sleep , as well as the complexity of the endocannabinoid system , and the ripple effect that thoughtful consumption can have. Sleep is not often the focus of clinicaltrials on cannabis; rather it is often a secondary outcome. Has CBN been proven to help with sleep?
Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Program between St. Bonaventure University and George Washington University School of Medicine. .
Following the successful experiment into the potential safety and efficacy of using ketamine for Parkinson’s patients, the university proceeded to sign an exclusive licensing partnership with Pharmather Inc. , Studying Ketamine Use for Parkinson’s Disease Patients. As many as 250 clinics across the U.S.
Additional, less common eating disorders include rumination disorder , which involves regurgitation of food without any subsequent compensatory behaviors; pica , which is the consumption of non-nutritious or no-food items; and restrictive food intake , winch involves under-eating without the body image issues of anoxia.
There have been a number of preclinical and clinicaltrials studying cannabis’ effects on pain. One of the major reasons cannabis grew so popular with medical marijuana patients is its perceived ability to manage pain, particularly pain that other medications can’t help. And this is an area of ample scientific research.
While antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal diagnosis to a manageable chronic condition, patients often endure chronic pain, nausea, appetite loss, and psychological distress. Medical marijuana for HIV/AIDS offers a promising complementary treatment for patients.
Elevated levels of stress can even land these individuals in more discomfort, with IBD patients risking hospitalization due to inflammation. Factors such as diet and stress are known to aggravate IBD patients, but they do not cause it. . What is IBS? What is the Difference Between IBD and IBS?
Legal cannabis consumption and it isn’t even legal yet. – ‘No definitive evidence’ – British charity Versus Arthritis recommends patients contemplating CBD should consult their doctor beforehand, and also wants more work done to understand its impact. Here we’re just talking about CBD.
Medical Marijuana in Cancer Care: Alleviating Pain and Mitigating Chemotherapy Side Effects Cancer patients often endure intense pain and debilitating side effects from chemotherapy. Both THC and CBD play roles in managing these symptoms, with some patients finding relief through the use of specific strains or formulations.
Note: Veriheal does not support illegally consuming therapeutic substances like MDMA but acknowledges that it transpires because of the current illicit status of both, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.
Aurelius Data, a company dedicated to providing data around plant-based medicines, warned the public Tuesday that THC and COVID-19 don’t mix, based on what they know about how cannabinoids affect patients with influenza. Additional research is also needed to determine if THC is in fact harmful to coronavirus patients.
Many patients are turning to cannabis for insomnia relief, seeking its potential to improve sleep quality and duration. In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers.
The study is published in the Journal of Medical Imaging and Radiation Sciences and titled Cannabis and Radiation Therapy: A Scoping Review of Human ClinicalTrials. “Most patients want to learn more about cannabis from their healthcare team, but most oncology professionals feel too uninformed to make recommendations. .”
Doctors have remained integral parts of a patient’s cannabis journey through what is known as the Access to Cannabis for Medical Purposes Regulation (ACMPR) act. These guidelines outline a list of qualifying conditions that patients must possess in order to legally obtain medical cannabis. Shedding Stigma and Promoting Patient Access.
Aside from Japan legalizing medical marijuana and forging a legal pathway that enables patients to use drugs made from cannabis plants, the amended legal law also seeks to criminalize the use of marijuana. Due to the country’s strict zero-tolerance approach to cannabis, rates of illicit consumption amongst adults are low. Around 0.2%
Because of the very rapid progression of ALS in the majority of patients, understanding how cannabis could help in the alleviation of symptoms is incredibly important for ALS sufferers. Both upper and lower motor neurons suffer severe damage in ALS patients. As few as 10% of ALS patients live longer than 10 years after being diagnosed.
The double-blind, randomised, placebo-controlled clinicaltrial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. hours after consumption. hours after consumption. Further simulator tests were given at 30 minutes, 1.5, hours after smoking.
The first path, that of traditional medicine, currently offers patients limited options. The only psychedelic drug that is approved (outside of clinicaltrials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. 2022 Active FDA ClinicalTrials and State-Regulated Systems.
More clinicaltrials are needed to establish definitive efficacy and safety profiles. The study also noted that patients using medical cannabis had improved quality of life. – Details: The research emphasized the need for controlled clinicaltrials to better understand the optimal dosages and strains.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content